In rheumatoid arthritis (RA), the aims of therapeutic strategies are to obtain remission and prevent joint destruction as early as possible. Although the effects of non-steroidal antiinflammatory drugs and corticosteroids initiate after a short time, they are not very sufficient in changing the process of rheumatoid arthritis and preventing the joint damage. For this reason, it has to be combined with disease modifying antirheumatic drugs (DMARD). Toxicity of the drugs should be monitored carefully. DMARD cannot fully control disease findings in most patients. There are alternative treatment regimes for unresponsive patients to classical treatment. Traditional and new drugs for rheumatoid arthritis will be reviewed separately
In rheumatoid arthritis (RA), the goals of therapeutic strategies are to obtain remission and prevent joint destruction as early as possible. Although the effects of non-steroidal anti-inflammatory drugs and corticosteroids initiate after a short time, they are not very sufficient in changing the process of rheumatoid arthritis and preventing joint damage. For this reason, it has to be combined with disease modifying antirheumatic drugs (DMARD). Toxicity of the drugs should be carefully monitored. DMARD cannot fully control disease findings in most patients. There are alternative treatment regimes for unresponsive patients to classical treatment. Traditional and new drugs for rheumatoid arthritis will be reviewed separately
Alan : Sağlık Bilimleri
Dergi Türü : Ulusal
Benzer Makaleler | Yazar | # |
---|
Makale | Yazar | # |
---|